drugset / Trial / NCT05644873

Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases

NCT05644873

Completed 48 enrolled Ondokuz Mayıs University
RandomizedParallel-groupDouble-blindSupportive care

Summary

In our study, it was aimed to show the contribution of intraoperative intravenous magnesium sulfate administration to peroperative opioid consumption and postoperative analgesia.

Timeline

Start
2023-11-15
Primary completion
2024-02-20
Completion
2024-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 20 mg/kg Intravenous

Indications

No indication recorded.